-PTI Clinical Drug Trials in India led to the death of 1144 people in 2010 and 2011, the government today said. The number of people dying during such trials also include 1106 people whose death could be attributed to diseases like cancer, terminal illness or various unrelated causes which is also known as Serious Adverse Event (SAE) of death, Health and Family Welfare Minister Ghulam Nabi Azad told the Rajya Sabha. "The number...
More »SEARCH RESULT
Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new Drug Trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »CDSCO drafting new norms for financial compensation-Mahim Pratap Singh
-The Hindu In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases. The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000. This makes 2011 only the second year, for which data are...
More »Maharashtra leads in drug trial-related deaths-Mahim Pratap Singh
-The Hindu Maharashtra recorded the maximum number of deaths due to serious adverse events (SAEs) during Drug Trials, while Madhya Pradesh saw the least number of such deaths. According to data disclosed by the Drug Controller-General of India, during the 49-month period (January 2008-January 2012), the country recorded 2,061 drug trial-related deaths. But data has been given only for 1,603 of the 2,061 deaths. Maharashtra recorded the maximum number of 268 deaths to...
More »India to join global HIV vaccine effort
-The Telegraph A global effort to create a vaccine against the human immunodeficiency virus (HIV) that has abandoned dozens of candidate vaccines because of unsatisfactory trials has persuaded India to join its new vaccine-design strategy. The Translational Health Sciences and Technology Institute, a government research centre in a Haryana suburb near Delhi, will set up a laboratory for basic research to seek out molecules that can generate antibodies to effectively neutralise HIV. India’s...
More »